You can buy or sell CKPT and other stocks, options, ETFs, and crypto commission-free!
Checkpoint Therapeutics, Inc. Common Stock, also called Checkpoint Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Read More Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Expected Nov 1, Pre-Market